Weekly Roundup: February 15-19, 2021

February 19, 2021
Morgan Petronelli, Associate Editor

ICYMI, some of this week’s featured content includes articles on the multiple modalities to revise scars, the future of dermatology, phase 3 results of tapinarof cream for plaque psoriasis, guidelines for the COVID-19 vaccine and dermal fillers, plus more.

POLL: Do you educate your patients about skin cancer?

The Mainstream Patient: February 15, 2021

This week’s edition of The Mainstream Patient features stories on hidradenitis suppurativa, the rise of contact dermatitis, sebaceous filaments, coconut oil for the face, plus more.

Customization Drives Pediatric Acne Treatment Regimens

Treatment regimens for pediatric acne should consider skin type, ethnicity, disease severity and personal preferences, according to one expert.

Cosmetic Moisturizers and Pharmaceutical Vehicles

In this month's Cosmetic Conundrums column, Dermatology Times Chief Medical Editor Zoe Diana Draelos, MD, details the difference between cosmetic moisturizers and pharmaceutical vehicles.

Multiple Modalities Help Revise Scars

From lasers to filler and microneedling, dermatologists have a broad menu of modalities for addressing the challenges of scars.

A Wave of Change Approaching for the Future Dermatology

Three experts chart game-changing innovations that will shift the boundaries of dermatology.

Guidelines Address COVID-19 Vaccine Concerns Related to Dermal Fillers

In the Moderna coronavirus disease 2019 (COVID-19) vaccine trials, 3 participants reported facial or lip swelling after receiving the vaccine. ASDS guidelines state that patients with a history of dermal filler injections should not void vaccinations.

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

In this episode, Gary Salman, CEO of Black Talon Security, details how to best protect your practice from data breaches and cybercriminals, as well as the risks of not implementing cybersecurity measures into your practice and what to do if a data or email breach occurs.

Phase 3 Results Support Long-Term Use of Tapinarof Cream

Dermavant announces positive results from an interim analysis of its PSOARING 3 safety study investigating tapinarof cream 1% for the treatment of plaque psoriasis in adult patients.

Treating Scars Through Multiple Modalities

Joel Cohen, MD, gives a synopsis of a panel discussion he was recently a part of at the 2021 ODAC Dermatology, Aesthetic and Surgical Conference focusing on the postoperative treatment of scars using a variety of methods including lasers, filler and other modalities.

Patient Safety Alert Issued Over Children Injecting HA via “Hyaluron Pens”

ASDSA has issued a patient safety alert after videos surface online of children/teens self-injecting HA via “hyaluron pens”.

Systemic Therapy Advances for Atopic Dermatitis

New treatments for atopic dermatitis offer more options with favorable safety and efficacy.

GLA Offers Promise as Add-on Therapy to Minocycline

Patients with rosacea can get better results by supplementing standard minocycline oral therapy with γ-linolenic acid (GLA), according to findings from a recent study.